ICU-acquired muscle weakness in COVID-19 patients who underwent lung transplantation  

作　　者：Juan Chen Bingqing Yue Jingyu Chen Man Huang 

机构地区：[1]General Intensive Care Unit,the Second Affi liated Hospital of Zhejiang University School of Medicine,Hangzhou 310014,China [2]Lung Transplantation Laboratory,the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310014,China [3]Department of Lung Transplantation,the Second Affi liated Hospital of Zhejiang University School of Medicine,Hangzhou 310014,China [4]Key Laboratory of Multiple Organ Failure(Zhejiang University),Ministry of Education,Hangzhou 310014,China [5]Wuxi Lung Transplant Center,Wuxi People's Hospital Affi liated to Nanjing Medical University,Wuxi 214043,China

出　　处：《World Journal of Emergency Medicine》2025年第1期94-96,共3页世界急诊医学杂志(英文)

摘　　要：Lung transplantation (LT)has emerged as a crucial life-saving option for critically ill patients with severe coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) or irreversible lung injury.[1]Intensive care unit-acquired weakness (ICU-AW)is a prevalent complication in critically ill patients.[2] The recovery of recipients undergoing LT for COVID-19-related respiratory failure may face impediments due to ICU-AW,which negatively affects early mobilization and functional improvement. This study describes two cases of successful bilateral LT for severe COVID-19-related ARDS with the occurrence of ICU-AW and subsequent successful discharge.

关 键 词：PATIENTS LUNG RESPIRATORY 

分 类 号：R655.3[医药卫生—外科学]